DIPG-25. GENETIC ALTERATIONS TARGETING THE MAPK PATHWAY CONFERS PRECLINICAL SENSITIVITY TO TRAMETINIB IN A CO-CLINICAL TRIAL IN DIPG
Izquierdo, Elisa, Carvalho, Diana, Boult, Jessica, Mackay, Alan, Temelso, Sara, Molinari, Valeria, Stubbs, Mark, Burke, Rosemary, Depani, Sarita, O’Hare, Patricia, Robinson, Simon, Hubank, Michael, HaТом:
21
Журнал:
Neuro-Oncology
DOI:
10.1093/neuonc/noz036.046
Date:
April, 2019
Файл:
PDF, 96 KB
2019
File converter
Більше результатів пошуку
More benefits 
